News
An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone," but experts say concerns ...
A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...
As the Food and Drug Administration undertakes a full agency review of the safety of the chemical abortion drug mifepristone, four pro-abortion attorneys general are asking the FDA to reverse course ...
Pro-life movement faces challenges as abortions remain frequent after Dobbs, focusing on defunding Planned Parenthood, ...
Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.
Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...
In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...
Journalist Rebecca Grant, who writes about reproductive rights, outlines the alternative healthcare methods that many are ...
(The Center Square) – On the three-year anniversary of the U.S. Supreme Court overturning Roe v Wade, dozens of state ...
In the second phase of CATALYST, individuals who had abnormal cortisol suppression were offered the opportunity to take part in a randomized trial of mifepristone, a medication that reduces the ...
A study reveals that chemical abortions cause more harm than reported, with 22 times higher adverse events than the FDA label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results